Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nitroglycerin in Trans-radial PCI
NCT06289946Phase 2Not yet recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of nitroglycerin in coronary artery disease (CAD), sponsored by Thomas Jefferson University. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
nitroglycerin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06289946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06289946.